NCT00369187View on ClinicalTrials.gov

Study of a Large Protein Molecule Administered With Escalating Doses of Recombinant Human Hyaluronidase

PHASE4CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 31, 2006

Study Completion Date

October 31, 2006

Conditions
Rheumatoid Arthritis
Interventions
DRUG

large protein molecule

Sponsors
All Listed Sponsors
lead

Halozyme Therapeutics

INDUSTRY

NCT00369187 - Study of a Large Protein Molecule Administered With Escalating Doses of Recombinant Human Hyaluronidase | Biotech Hunter | Biotech Hunter